News

How an innovative digital platform supports precision medicine

XO Life introduces an innovative communication platform.

World
18.10.2023

The medical world is experiencing enormous advancements due to technological progress, particularly in precision medicine, which enables individually optimized treatments for patients. Nevertheless, there are challenges in putting this advanced medicine into practice, as many patients still receive the wrong medication. This is partly due to inadequate testing of new drugs. The German software company XO Life has taken on this ethical problem. Following the development of the nebenwirkungen.de platform, which enables users to anonymously report intolerances to the manufacturer, XO Life has now created a communication platform that connects patients, doctors, pharmacists and drug manufacturers. It is the first digital exchange platform of its kind in the world.

XO Life's innovative digital real-world evidence platform, which was developed in a two-year collaboration with experts, enables patients to share their experiences with drug treatments anonymously and in real time using a standardized scientific survey process. The collected consumer experiences are recorded in a structured manner in the ImpactMonitor and serve as the basis for personalized risk-benefit profiles of therapies. The adaptive software-as-a-service solution Pharmacoviligance offers medical professionals a modern communication infrastructure that can be extended by telemedicine services and impresses with its seamless data security.

MedWatcher

Contact

E-mail

Contact for companies:

fachkreise@xo-life.com

Press

Our press contact for inquiries:

presse@medwatcher.io

Office

We can also be reached by classical means:

XO Life Ltd.
Agnes Pockels Arc 180992 Munich

The MedWatcher is in demand.

Stay up to date.

Two million euros for XO Life GmbH

XO Life raises over 2 million euros for the expansion of the Patient Insights platform.
Read article
PressBOX
18.10.23

How a platform makes big data usable for medicine

MedWatch supports medical research by collecting real-world evidence.
Read article
Handelsblatt
18.10.23

One night, ten pitches: These start-ups present themselves

MedWatcher presented the benefits and features at Pitch Night 2023.
Read article
en:hub
18.10.23

Position yourself and your pharmacy as a health advisor with MedWatcher

MedWatcher and "FRAG DIE APOTHEKE" connect end customers, pharmacists and the pharmaceutical industry.
Read article
TheDigitalPharmacy
18.10.23

Medwatcher: Instagram for patients

MedWatcher, the "Instagram for Patient:ins," provides a platform for reliable drug information.
Read article
Pharmacy adhoc
18.10.23

MedWatcher creates access to valuable feedback from cancer patients

MedWatcher, in cooperation with the EORTC, gives cancer patients access to standardized questionnaires.
Read article
PRESSEPortal
18.10.23

MedWatcher: Patient information for research

MedWatcher and EORTC collaborate to support cancer patients and research through real-world data.
Read article
Pharma Relations
18.10.23

Patient platform MedWatcher wants to cooperate with pharmacies

MedWatcher partners with "Ask the Pharmacy" to provide specialized health information.
Read article
German Pharmacist Newspaper
18.10.23